SCHEMBL10157136

SCHEMBL10157136

CC(C)=CC(=O)NCc1cccnc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.65
RECQL P46063 1/20 0.60
PKM P14618 1/20 0.57
KMT2A Q03164 1/20 0.57
THRB P10828 1/20 0.56
MAPT P10636 2/20 0.56
ALDH1A1 P00352 4/20 0.55
POLB P06746 2/20 0.55
FES P07332 1/20 0.55
RET P07949 1/20 0.55
MARK3 P27448 1/20 0.55
TYK2 P29597 1/20 0.55
FLT4 P35916 1/20 0.55
SYK P43405 1/20 0.55
CLK2 P49760 1/20 0.55
CLK4 Q9HAZ1 1/20 0.55
HTT P42858 3/20 0.54
NPSR1 Q6W5P4 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2698425 0.86 USP2 (0.70) USP2RECQLPKMKMT2ATHRB
SCHEMBL7666539 0.83 USP2 (0.55) USP2RECQLPKMKMT2ATHRB
SCHEMBL7666543 0.83 USP2 (0.55) USP2RECQLPKMKMT2ATHRB
SCHEMBL7666536 0.83 USP2 (0.55) USP2RECQLPKMKMT2ATHRB
SCHEMBL45843 0.82 RECQL (0.70) USP2RECQLPKMKMT2AMAPT
SCHEMBL774098 0.81 USP2 (0.68) USP2RECQLPKMKMT2ATHRB
SCHEMBL31321078 0.81 USP2 (0.68) USP2RECQLPKMKMT2ATHRB
SCHEMBL31321074 0.81 USP2 (0.68) USP2RECQLPKMKMT2ATHRB
SCHEMBL10157134 0.81 ALDH1A1 (0.61) MAPTALDH1A1HTTNPSR1CYP3A4
SCHEMBL26125902 0.81 USP2 (0.63) USP2RECQLPKMKMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10189810-B2 Pyrazolyl-substituted pyridone compounds as serine protease inhibitors VERSEON CORPORATION (US) 2019-01-29 US disclosed
US-20170267656-A1 PYRAZOLYL-SUBSTITUTED PYRIDONE COMPOUNDS AS SERINE PROTEASE INHIBITORS VERSEON INTERNATIONAL CORPORATION 2017-09-21 US disclosed
US-8895551-B2 Acrylamide compounds and the use thereof SHIONOGI & CO., LTD. (JP) 2014-11-25 US disclosed
US-20120022069-A1 ACRYLAMIDE COMPOUNDS AND THE USE THEREOF SHIONOGI & CO., LTD. (JP) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022069-A1 ACRYLAMIDE COMPOUNDS AND THE USE THEREOF TRPA1, TRPV1, CACNA1B USP2 2240/4885RECQL 673/4885PKM 4138/4885
US-20170267656-A1 PYRAZOLYL-SUBSTITUTED PYRIDONE COMPOUNDS AS SERINE PROTEASE INHIBITORS SERPINE1, PRSS1, SPINT2 USP2 2512/4885RECQL 1004/4885PKM 228/4885
US-10189810-B2 Pyrazolyl-substituted pyridone compounds as serine protease inhibitors SERPINE1, PRSS1, SPINT2 USP2 2512/4885RECQL 1004/4885PKM 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.